The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Clinical features and treatment of adenovirus infections
Abstract
Adenoviruses (Ads) are common opportunistic pathogens that are rarely associated with severe clinical symptoms in healthy individuals. In contrast, in patients with compromised immunity, Ad infections often result in disseminated and potentially life‐threatening disease. Among these are AIDS patients, individuals with hereditary immunodeficiencies and recipients of solid organ or haematopoietic stem cell transplants (HSCT) who receive immunosuppressive therapy. The latter account for the largest number of severe Ad infections. There is currently no formally approved antiviral therapy for the treatment of severe Ad keratoconjunctivitis and life‐threatening Ad infections in immunocompromised patients. Here we update current knowledge on Ad biology, the clinical features observed in different patient groups and specific immune responses towards Ad infections. In addition, we review current and future treatment options, including: (i) the antiviral drugs cidofovir, ribavirin and new investigational compounds, as evaluated in the clinic or in relevant animal models, as well as (ii) novel immunotherapeutic strategies. Copyright © 2008 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrott, R. H., & Ward, T. G. (1953) · Experimental Biology and Medicine · doi:10.3181/00379727-84-20714 · Cited by 1,114
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 792
The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction
Cohen, C. J., Shieh, J. T. C., Pickles, R. J., Okegawa, T., Hsieh, J.-T., & Bergelson, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261452898 · Cited by 698
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Acyclic nucleoside phosphonates: a key class of antiviral drugs
Clercq, E. D., & Holý, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1877 · Cited by 688
Update on adenovirus and its vectors
Russell, W. C. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2573 · Cited by 596
Adenoviruses in the immunocompromised host
Hierholzer, J. C. (1992) · Clinical Microbiology Reviews · doi:10.1128/cmr.5.3.262 · Cited by 587
Mechanisms of action of ribavirin against distinct viruses
Graci, J. D., & Cameron, C. E. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.483 · Cited by 549
Feuchtinger, T., Matthes‐Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F. R., Beck, R., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06108.x · Cited by 394
Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., & Wold, W. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2296-2306.1996 · Cited by 375
Zhu, J., Huang, X., & Yang, Y. (2007) · Journal of Virology · doi:10.1128/jvi.02192-06 · Cited by 366
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.
Ginsberg, H. S., Moldawer, L. L., Sehgal, P. B., Redington, M., Kilian, P. L., Chanock, R. M., & Prince, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1651 · Cited by 353
The impact of adenovirus infection on the immunocompromised host
Kojaoghlanian, T., Flomenberg, P., & Horwitz, M. S. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.386 · Cited by 333
Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes
Garnett, C. T., Erdman, D., Xu, W., & Gooding, L. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10608-10616.2002 · Cited by 328
Dechecchi, M. C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M., & Cabrini, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8772-8780.2001 · Cited by 291
Brunetti-Pierri, N., Palmer, D. J., Beaudet, A. L., Carey, K. D., Finegold, M., & Ng, P. (2004) · Human Gene Therapy · doi:10.1089/10430340460732445 · Cited by 256
Inhibition of adenovirus infection and adenain by green tea catechins
Weber, J. M., Ruzindana-Umunyana, A., Imbeault, L., & Sircar, S. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00212-7 · Cited by 225
Muruve, D. A., Cotter, M. J., Zaiss, A. K., White, L. R., Liu, Q., Chan, T., Clark, S. A., Ross, P. J., Meulenbroek, R. A., Maelandsmo, G. M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5966-5972.2004 · Cited by 201
Cell Receptors Involved in Adenovirus Entry
Nemerow, G. R. (2000) · Virology · doi:10.1006/viro.2000.0468 · Cited by 194
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors
Short, J. J., Pereboev, A. V., Kawakami, Y., Vasu, C., Holterman, M. J., & Curiel, D. T. (2004) · Virology · doi:10.1016/j.virol.2004.02.016 · Cited by 164
Kirsi, J. J., North, J. A., McKernan, P. A., Murray, B. K., Canonico, P. G., Huggins, J. W., Srivastava, P. C., & Robins, R. K. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.3.353 · Cited by 163
Antiadenovirus Activities of Several Classes of Nucleoside and Nucleotide Analogues
Naesens, L. M. J., Lenaerts, L., Andreï, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1010-1016.2005 · Cited by 156
Self-citationA New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells
Tuve, S., Wang, H., Ware, C. B., Liu, Y., Gaggar, A., Bernt, K. M., Shayakhmetov, D. M., Li, Z., Strauss, R., Stone, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01370-06 · Cited by 154
Bruno, B., Gooley, T. A., Hackman, R. C., Davis, C., Corey, L., & Boeckh, M. (2003) · Transplantation and Cellular Therapy · doi:10.1016/s1083-8791(03)00102-2 · Cited by 152
Arnberg, N., Kidd, A. H., Edlund, K., Olfat, F. O., & Wadell, G. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7691-7693.2000 · Cited by 151
Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir
Quenelle, D. C., Collins, D. J., Wan, W., Beadle, J. R., Hostetler, K. Y., & Kern, E. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.404-412.2004 · Cited by 150
Immune Reconstitution and Clearance of Human Adenovirus Viremia in Pediatric Stem‐Cell Recipients
Heemskerk, B., Lankester, A. C., van Vreeswijk, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427513 · Cited by 147
Leen, A. M., Sili, U., Vanin, E. F., Jewell, A. M., Xie, W., Vignali, D. A. A., Piedra, P. A., Brenner, M. K., & Rooney, C. M. (2004) · Blood · doi:10.1182/blood-2004-02-0646 · Cited by 143
Symeonidis, N., Jakubowski, A. A., Pierre‐Louis, S., et al. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00184.x · Cited by 143
Mistchenko, A. S., Diez, R. A., Mariani, A. L., Robaldo, J. F., Maffey, A. F., Bayley-Bustamante, G., & Grinstein, S. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81360-5 · Cited by 141
The adenovirus capsid: major progress in minor proteins
Vellinga, J., van der Heijdt, S., & Hoeben, R. C. (2005) · Journal of General Virology · doi:10.1099/vir.0.80877-0 · Cited by 140
A New Animal Model for Human Respiratory Tract Disease Due to Adenovirus
Pacini, D. L., Dubovi, E. J., & Clyde, W. A. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/150.1.92 · Cited by 130
Antiviral cyclic d,l-α-peptides: Targeting a general biochemical pathway in virus infections
Horne, W. S., Wiethoff, C. M., Chunli, C., Wilcoxen, K., Amorín, M., Ghadiri, M. R., & Nemerow, G. R. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.051 · Cited by 129
Hillenkamp, J., Reinhard, T., Ross, R. S., Böhringer, D., Cartsburg, O., Roggendorf, M., Clercq, E. D., Godehardt, E. A. J., & Sundmacher, R. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00992-2 · Cited by 122
A Large Outbreak of Epidemic Keratoconjunctivitis: Problems in Controlling Nosocomial Spread
Warren, D., Nelson, K. E., Farrar, J. A., et al. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.6.938 · Cited by 121
Mul, Y. M., Verrijzer, C. P., & van der Vliet, P. C. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5510-5518.1990 · Cited by 112
Feuchtinger, T. F., Lang, P., Hamprecht, K., Schumm, M., Greil, J., Jahn, G., NIETHAMMER, D., & Einsele, H. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2003.12.009 · Cited by 108
Guida, J. D., Fejér, G., Pirofski, L., Brosnan, C. F., & Horwitz, M. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7674-7681.1995 · Cited by 105
Postentry Neutralization of Adenovirus Type 5 by an Antihexon Antibody
Varghese, R. T., Mikyas, Y., Stewart, P. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12320-12332.2004 · Cited by 105
Avivi, I. M., Chakrabarti, S., Milligan, D. W., Waldmann, H., Hale, G., Osman, H. K. E., Ward, K. N., Fegan, C., Yong, K., Goldstone, A. H., et al. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2003.11.001 · Cited by 100
Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection
Arnold, D., Biase, A. M. D., Marchetti, M., Pietrantoni, A., Valenti, P., Seganti, L., & Superti, F. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00197-8 · Cited by 94
Hong, S. S., Habib, N. A., Franqueville, L., Jensen, S., & Boulanger, P. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10366-10375.2003 · Cited by 90
Heemskerk, B., Veltrop‐Duits, L. A., van Vreeswijk, T., ten Dam, M. M., Heidt, S., Toes, R. E. M., van Tol, M. J. D., & Schilham, M. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6562-6566.2003 · Cited by 90
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Gordon, Y. J., Romanowski, E. G., & Araullo-Cruz, T. (1994) · PubMed · Cited by 85
Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins
Tang, J., Olive, M., Pulmanausahakul, R., Schnell, M. J., Flomenberg, N., Eisenlohr, L. C., & Flomenberg, P. R. (2006) · Virology · doi:10.1016/j.virol.2006.01.024 · Cited by 83
Crooks, B., Taylor, C., Turner, A. J., Osman, H., Abinun, M., Flood, T., & Cant, A. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702656 · Cited by 71
Chiang, L., Cheng, H., Liu, M.-C., Chiang, W. C., & Lin, C. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1600 · Cited by 64
Kajon, A. E., Gigliotti, A. P., & Harrod, K. S. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10475 · Cited by 61
Das, A., Trousdale, M. D., Ren, S., & Lien, E. J. C. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00070-4 · Cited by 60
Daluge, S. M., Purifoy, D. J. M., Savina, P. M., Clair, M. H. S., Parry, N. R., Dev, I. K., Novak, P., AYERS, K. M., Reardon, J. E., & Roberts, G. B. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1590 · Cited by 60
Kodama, E. N., Shigeta, S., Suzuki, T., & Clercq, E. D. (1996) · Antiviral Research · doi:10.1016/0166-3542(96)06966-5 · Cited by 58
Quantitative Analysis of Adenovirus-Specific CD4 + T-Cell Responses from Healthy Adults
Olive, M., Eisenlohr, L. C., & Flomenberg, P. R. (2001) · Viral Immunology · doi:10.1089/08828240152716646 · Cited by 57
Innate Immune Response to Adenovirus
Nazir, S. A., & Metcalf, J. P. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.53605 · Cited by 56
Charles, P. C., Guida, J. D., Brosnan, C. F., & Horwitz, M. S. (1998) · Virology · doi:10.1006/viro.1998.9180 · Cited by 47
Moore, M. L., McKissic, E. L., Brown, C. C., Wilkinson, J. E., & Spindler, K. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5584-5590.2004 · Cited by 47
Heemskerk, B., van Vreeswijk, T., Veltrop‐Duits, L. A., Sombroek, C. C., Franken, K. L. M. C., Verhoosel, R. M., Hiemstra, P. S., van Leeuwen, D., Ressing, M. E., Toes, R. E. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8851 · Cited by 44
Kitchen, L. W., & Vaughn, D. W. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.030 · Cited by 42
Mangel, W. F., Baniecki, M. L., & McGrath, W. J. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2318-2 · Cited by 40
Romanowski, E. G., Yates, K. A., & Gordon, Y. J. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00166-8 · Cited by 38
Pang, Y., Xu, K., Kollmeyer, T. M., Perola, E., McGrath, W. J., Green, D. T., & Mangel, W. F. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02672-2 · Cited by 36
Lenaerts, L., Verbeken, E. K., Clercq, E. D., & Naesens, L. M. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4689-4699.2005 · Cited by 35
Self-citationNitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo
Cao, W., Baniecki, M. L., McGrath, W. J., Bao, C., Deming, C., Rade, J. J., Lowenstein, C. J., & Mangel, W. F. (2003) · The FASEB Journal · doi:10.1096/fj.03-0396fje · Cited by 29
Cited by
Ocular Tropism of Respiratory Viruses
Belser, J. A., Rota, P. A., & Tumpey, T. M. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00058-12 · Cited by 360
Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant
Sutrave, G., Blyth, E., & Gottlieb, D. J. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.07.012 · Cited by 20
Metadata
- Authors
- Lenaerts, L., De Clercq, E., & Naesens, L.
- Venue
- Reviews in Medical Virology
- Publisher
- Wiley
- Published
- 2008-07-23
- Volume
- 18
- Issue
- 6
- Pages
- 357-374
- ISSN
- 1052-9276 (ISSN-L)
- 1099-1654
- OpenAlex
- W2159819482
- Cited by
- 255
- References
- 63
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.